CliffBio
small molecule

FALLBACK SOLO

LEVONORGESTREL

Loss of exclusivity—loss of exclusivity
CompanyLupin →See this company's full patent-cliff portfolio

Drug detail

Brand nameFALLBACK SOLO
Active ingredientLEVONORGESTREL
Strength1.5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalJune 2014
Marketing statusOTC

More from Lupin

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.